Trust Company’s Lam Research LRCX Stock Holding History

Trust Company’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.9K	Hold	9	–	–	﹤0.01%	501
2026 Q1	$1.92K	Hold	9	–	–	﹤0.01%	528
2025 Q4	$1.54K	Buy	+9	New	+$1.4K	﹤0.01%	531

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trust Company's LRCX Position: Q2 2026 in Review

Trust Company held its Lam Research (LRCX) position steady in Q2 2026 at 9 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

Trust Company first reported a position in LRCX in Q4 2025 and has held it in 3 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Trust Company held 9 shares of Lam Research worth $3.9K as of Q2 2026.
Trust Company left its Lam Research share count unchanged in Q2 2026.
Lam Research made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #501 holding.
Trust Company first reported a position in Lam Research in Q4 2025 and has held it in 3 quarters since.
3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.